target_chembl_id,target_organism,document_journal,document_year,activity_id,standard_type,molecule_pref_name,target_pref_name,assay_chembl_id,bao_format,pchembl_value,assay_description
CHEMBL378,Human immunodeficiency virus 1,J. Nat. Prod.,2007,2061738,IC50,MIRABAMIDE C,Human immunodeficiency virus 1,CHEMBL942898,BAO_0000218,6.84,Inhibition of HIV HXB2 in TZM-bl cells after 48 hrs by neutralization assay
CHEMBL378,Human immunodeficiency virus 1,J. Nat. Prod.,2007,2061743,IC50,MIRABAMIDE C,Human immunodeficiency virus 1,CHEMBL942899,BAO_0000218,6.0,Inhibition of HIV SF162 in TZM-bl cells after 48 hrs by neutralization assay
CHEMBL378,Human immunodeficiency virus 1,J. Nat. Prod.,2007,2061748,IC50,MIRABAMIDE C,Human immunodeficiency virus 1,CHEMBL942900,BAO_0000218,5.89,Inhibition of HIV LAV in BSC1 cells after 2.5 hrs by cell fusion assay
CHEMBL3879801,None,J. Nat. Prod.,2007,2061758,IC50,MIRABAMIDE C,NON-PROTEIN TARGET,CHEMBL942901,BAO_0000219,5.66,Cytotoxicity against human TZM-bl cells after 24 hrs by MTT assay
CHEMBL378,Human immunodeficiency virus 1,J. Nat. Prod.,2011,5314278,IC50,MIRABAMIDE C,Human immunodeficiency virus 1,CHEMBL1692275,BAO_0000218,6.91,Inhibition of HIV1 isolate YU2 infected in human TZM-bl cells expressing CD4 and CCR5 assessed as assessed inhibition of viral entry after 24 hrs by luciferase reporter assay
